Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hunter Group ASA - Annual General Meeting held on 30 June 2023

Oslo, 30 June 2023 The Annual General Meeting ("AGM") in Hunter Group ASA (the "Company") took place today on 30 June 2023 at 10:00 hours CET. All resolutions were passed in accordance with the proposals set out in the notice for the EGM, including the 20:1 reverse stock split. The shares in the Company will trade ex. the reverse split on 3 July 2023. Following the reverse stock split, the Company will have 28,768,101 shares outstanding.  The minutes from the AGM are attached to this announcement and will be made available on the Company's website: www.huntergroup.no. Contact:

SLP carries out its largest new construction project so far - signs a 15-year lease with Ahlsell for 60,000 sqm

SLP has today signed an agreement to acquire a property of 280,000 square meters in Hallsberg and signed a 15-year lease regarding an environmentally certified new construction of just over 60,000 square meters. The estimated transaction value amounts to just over SEK 800 million and would imply an annual rent of approximately SEK 50 million. The lease, which runs for 15 years, is signed with Ahlsell Sweden and is indexed with CPI. Access to the property takes place preliminary during the third quarter and the new construction is expected to be completed at the turn of the year 2024/2025."

ASCO 2023 - good news for CHOSA

· Immuno Oncology with PD1 inhibitors successful in NSCLC in combination with cisplatin. · CHOSA’s DRP has the potential to turn this combination into precision therapy. CHOSA Oncology AB ("CHOSA") presents highlights from the American Society of Clinical Oncology (ASCO) in a video on the homepage.Listen to CEO Peter Buhl Jensen’s presentation here  Previously communicated abstract on LiPlaCis data presented at ASCO can be found here  .

LeadDesk strengthens its telco business by acquiring the entire share capital of Länsilinkki Oy – "Takes our telecom operator service to a whole new level."

LeadDesk Plc Unofficial Translation of Press Release 30/6/2023 at 1.45 pm. In case the document differs from the original, the Finnish version prevails.LeadDesk is a leader in European cloud-based contact center software and is currently investing heavily in developing AI features. The company strengthens its telecom operator business (CPaaS – Communication Platform as a Service business) by acquiring the entire share capital of Länsilinkki Oy. The acquisition will enhance LeadDesk's competitiveness and service offering in the telecom operator business. At the same time, LeadDesk's product

Resolutions from the Annual General Meeting 2023 in Pharmacolog i Uppsala

The English translation of the resolutions is an unofficial translation of the Swedish original. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders of Pharmacolog i Uppsala AB (publ) held the Annual General Meeting on June 30, 2023 in Uppsala.Annual report and resultsThe annual report and auditor's report were presented and the income statement and balance sheet were adopted. It was decided to dispose of the company's earnings in accordance with the Board's proposal. Discharge from liabilityThe Annual

Cloudberry Clean Energy ASA | Successfully completes sale of assets

Oslo, Norway, 30 June 2023: 16[th] of June 2023 Cloudberry (“Cloudberry” or the “Company”) announced the signing of a share sale and purchase agreement with Norsk Vannkraft AS (“Norsk Vannkraft”) for the sale of the three hydropower plants Åmotsfoss, Selselva and Nessakraft.Today, Cloudberry announces the successful completion of the transaction, yielding an internal rate of return (IRR) of above 55% p.a. for the Company and generating free cash of approximately NOK 500 million. The total transaction value is NOK 703 million, on a debt and cash free basis. The equity value of the shares to

Vestas wins 151 MW order in Spain

News release from Vestas MediterraneanMadrid, 30 June 2023 Vestas has secured a 151 MW order for several wind parks in Spain. The contract includes the supply and installation of 26 V136-4.5 MW, three V163-4.5 MW wind tubines and another five V136-4.5 MW wind turbines delivered in 4.0 operating mode. The  contract includes a 15-year Active Output Management 5000 (AOM 5000) service agreement. The projects and customer are undisclosed. Turbine delivery is expected to start in the second half of 2024 whilst commissioning is planned for the last quarter of 2024 and the first half of

Notice of filing of new patent application for VAL001

Respiratorius announces that a patent application for the completed formulation of VAL001 has been filed. The patent application protects the formulation of valproate, which in a PK study has shown expected results.The patent application protects a new oral formulation of sodium valproate for the pretreatment of cancer, as well as any other use of the formulation. The application is valid for at least 20 years from the date of priority, during which time it confers exclusive rights on the market. The tailored release profile of VAL001, which combines immediate-release and­ delayed-

NEW WAVE GROUP AB (PUBL) acquires TENSON

New Wave Group has today acquired 100% of the shares in the Swedish outdoor company Tenson AB.Tenson AB, the Swedish outdoor & lifestyle brand with roots from the Swedish west coast (founded in Varberg 1951) has over the past four years undergone a restructuring & repositioning process that included the entire spectrum regarding brand, product, marketing, sales and channel strategies. Through the acquisition and integration of the company, New Wave Group will give Tenson access to the resources and synergies required to enter the next phase of the above-mentioned process - to scale up

Annual Financial Report

Investec Bank plcIncorporated in England and WalesRegistration number 489604LEI: 84S0VF8TSMH0T6D4K848 Investec Bank plc (the "Company") Annual Report and Financial Statements In compliance with the Listing Rules of the United Kingdom Listing Authority (the "UKLA"), the Company's Annual Report and Financial Statements for the year ended 31 March 2023 (the "Annual Report and Financial Statements") have been issued today and can be viewed on the Company's website: www.investec.com/annualreports A copy of the Annual Report and Financial Statements will be submitted to the

Jetpak and KookieJar of Sweden AB in collaboration to enable goods transport with drones

Greentech company KookieJar and logistics company Jetpak have today signed a letter of intent to cooperate in alliance with KookieJar's scalable vertiport strategy that aims to enable the safe and efficient transport of goods with drones, facilitating deliveries to multiple nodes in Swedish cities. The collaboration will focus on the development of drone technology with its challenges and opportunities for the transport of goods with drones in larger volumes. The goal of the collaboration for Jetpak and KookieJar is to develop a format for the business benefit of flying goods and

Metsä Group's major customer Finsilva to adopt Metsä Group Plus in its forests

Finsilva plc, one of Finland’s largest forest owners, will adopt the Metsä Group Plus forest management model for measures carried out in its forests. The Metsä Group Plus model calls for more retention trees, burned wood, high biodiversity stumps and protective thickets in the forest and wider buffer zones along waterways than conventional models. “Finsilva aims to continuously develop forestry in a more sustainable and profitable direction. The development of technology and planning systems allows even more precise and detailed nurturing and promotion of nature values, along with

Redsense has submitted application for cross-trading at OTCQX Best Market in the US

OTCQX is a trading platform in the United States operated by the OTC Markets Group for securities not listed on a national stock exchange. The purpose of a cross-trading on OTCQX is to satisfy an increasing interest from US investors and to increase accessibility to the US capital market. Upon possible approval, Redsense Medical shares will be traded with a US ticker symbol and a share price in USD, in US market hours. "Given that Redsense Medical has most of its revenue in the US, it is also natural that we initiate a process to facilitate for North American investors to trade in the

#23-60 Decision on delisting of Paydrive AB from Nordic SME

Paydrive AB ("the Company"), whose shares are listed on Nordic SME, disclosed a public takeover offer from Dina Försäkringar AB to the shareholders in Paydrive AB on May 9, 2023. On June 30, 2023, the Company issued a press release with information that Dina Försäkringar AB had achieved control of approximately 97,84 percent of the shares in the Company. The press release also stated that Dina Försäkringar AB intended to commence a compulsory acquisition procedure to acquire the remaining shares in the Company and that the Company had decided to apply for delisting of its shares and

BioStock: Phase II results indicate durability of response for Alligator’s CD40 agonist

Alligator Bioscience has presented a second round of interim results from a phase II trial with mitazalimab in pancreatic cancer patients. The follow-up evaluation on the first 23 patients shows an objective response rate of 57 per cent – up from 52 per cent at the first evaluation reported in January. The evaluation on the full set of 57 patients reveals an objective response rate of 44 per cent – also susceptible to an increase as the study progresses. More data points indicate that mitazalimab provides a durable response in combination with standard of care chemotherapy. To give us an in-

Vestas wins 74 MW EnVentus order in Italy

News release from Vestas MediterraneanMadrid, 30 June 2023 Italy-based engineering and construction company SIMIC has placed a 74 MW order for the Villacidro and Musei wind parks, to be located in Sardinia, Italy. The contract includes the supply and installation of 12 V162-6.2 MW wind turbines, as well as a 20-year Active Output Management 5000 (AOM 5000) service agreement. “With Villacidro and Musei wind parks, SIMIC achieves an important milestone of more than 100 MW of solar and wind installed capacity and confirms its commitment to energy transition and sustainability”, says

Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares

(Stockholm, Sweden, June 30, 2023) - Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that as of June 30, 2023, the total number of issued shares of common stock is 90,242,332 of which 85,374,054 shares are outstanding.Autoliv retired 475,292 shares of common stock that had been repurchased during the quarter which resulted in a decrease in the issued shares. The Company now has a total of 90,242,332 issued shares of common stock of which 85,374,054 shares are outstanding. Each share of outstanding common stock is entitled to

Björn Sundmark named to the jury of the Astrid Lindgren Memorial Award

The Swedish Arts Council Board has named Björn Sundmark, Professor of English Literature at Malmö University, to the jury for the Astrid Lindgren Memorial Award. Sundmark takes up the position on 1 July. ‘Björn Sundmark has wide-ranging experience and expertise in the field of literature for children and young people. Through his research, he is active in an international context and has a wide network. His qualifications make him an excellent complement to the existing makeup of the jury,’ says Bongi MacDermott, Director of International Cooperation for the Arts Council. Björn

BioStock: First patient dosed in Abliva’s Falcon study

In December Abliva started its phase II study to evaluate KL1333 in patients with primary mitochondrial disease. Earlier this week the company announced that the first patient in the study has been dosed. BioStock contacted Abliva CEO Ellen K. Donnelly to ask what this milestone means for the company.Read the article at biostock.se: https://www.biostock.se/en/2023/06/first-patient-dosed-in-ablivas-falcon-study/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Flexion welcomes game-changing initiative in app distribution market

Reports confirm that Meta is joining the alternative market as EUs Digital Market Act gains momentumLONDON, 30th of June 2023 – Flexion (Nasdaq: FLEXM), the games marketing company welcomes reports that Meta is planning to support developers  in the EU with a new service which by-passes Google Play and the App Store. As reported in the Verge, Meta is planning to let people in the EU directly download apps through Facebook ads, setting the company up to eventually compete with Google and Apple’s app

Dolphin Drilling AS: PDMR notification

Oslo, 30 June 2023: Reference is made to the stock exchange announcement by Dolphin Drilling AS (the "Company") on 30 June 2023 regarding approval by the extraordinary general meeting of the conditions for completion of the Private Placement announced on 22 June 2023. Reference is further made to the conditional allocation of offer shares to S.D. Standard ETC Plc ("SDS") in the Private Placement. SDS is a close associate to Martin Nes, chair of the Company's board of directors. In order to facilitate settlement in the Private Placement SDS has today, through an agreement with the

M.O.B.A. publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

On 26 May 2023, M.O.B.A. Network AB (publ) (the “Company”) successfully issued senior secured bonds in an initial amount of EUR 25 million, under a total framework of EUR 60 million (the “Bonds”). Pursuant to the terms and conditions for the Bonds, the Company has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For this purpose, the company has prepared a listing prospectus, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available at the company’s website

BioStock: First patient dosed in Abliva’s Falcon study

In December Abliva started its phase II study to evaluate KL1333 in patients with primary mitochondrial disease. Earlier this week the company announced that the first patient in the study has been dosed. BioStock contacted Abliva CEO Ellen K. Donnelly to ask what this milestone means for the company.Read the full article at biostock.se : https://www.biostock.se/en/2023/06/first-patient-dosed-in-ablivas-falcon-study/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

There are no items matching the current filter
There are no more items matching the current filter
Back to top